Description The purpose of this best practice advice (BPA) article from the Clinical Practice
Update Committee of the American Gastroenterological Association is to provide an update …

Key Clinical Points Gastroesophageal Reflux Disease Patients with heartburn and
symptoms such as dysphagia, odynophagia, weight loss, anorexia, gastrointestinal …

Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal
reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly …

Background Because trends in the epidemiology and burden of gastroesophageal reflux
disease (GERD) are changing, reinvestigating the geographical differences and trend …

Background & Aims For decades, proton pump inhibitors (PPIs) have been the mainstay of
treatment for erosive esophagitis. The potassium-competitive acid blocker vonoprazan …

Background: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …

Abstract Proton Pump Inhibitors are used widely to manage many gastric acid-related
conditions such as gastroesophageal disease, gastritis, esophagitis, Barrett's esophagus …

Gastroesophageal Reflux Disease (GERD) is a chronic ailment that results from the
backward flow of stomach acid into the esophagus, causing heartburn and acid …

Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

• Proton pump inhibitors (PPIs) are effective and widely used, but often for longer than
needed, adding to medication burden and resource waste• Discuss with patients reducing or …